Probiotic lotion for hair loss
Part of Skin clinical trials.
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have doctor-diagnosed male or female pattern baldness, with mild to moderate thinning (not complete baldness).
- You are between 18 and 60 years old and generally healthy.
- You have not used any hair loss medications (like minoxidil or finasteride) in the last 6 months.
- Your hair loss has not been steadily getting worse for more than 5 years.
- You do not have active scalp infections, psoriasis, uncontrolled diabetes, or heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining platelet-rich plasma (PRP) injections with botulinum toxin type A (Botox) can help regrow hair in people with male or female pattern baldness. It aims to see if this combination is safe and effective for treating androgenetic alopecia.
This trial tests whether a low-dose oral form of minoxidil (a common hair-loss medicine) can help people with mild to severe male or female pattern baldness.
This trial tests a new oral (pill) form of minoxidil to help regrow hair in men with male-pattern baldness. Minoxidil is a known hair-growth medication, and this study evaluates whether taking it as a pill works safely and effectively.
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.